Discover
ENGN
enGene Therapeutics Inc.
1.76
2 x 1.29
2 x 2.22
bid
ask
+
0.03
1.73%
2 @ 07:33 AM
1.73 -0.03 (1.70%)
| Ytd | -80.51% | |
| 1y | -51.38% |
1.73
day range
1.78
1.40
52 week range
12.25
| Open | 1.74 | Prev Close | 1.73 | Low | 1.73 | High | 1.78 | Mkt Cap | 117.90M |
| Vol | 605.23K | Avg Vol | 1.74M | EPS | -2.18 | P/E | N/A | Forward P/E | -3.53 |
| Beta | -0.76 | Short Ratio | 11.39 | Inst. Own | 83.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-14 | 50-d Avg | 3.15 | 200-d Avg | 6.95 | 1yr Est | 27.00 |
| Income Statement | |||
| Operating Expenses | 31.97M | ||
| Research and Development Expense | 22.20M | ||
| Selling, General and Administrative Expense | 9.77M | ||
| Operating Income | -31.97M | ||
| Interest Expense | 745.00K | ||
| Net Income | -30.23M | ||
| Net Income Common Stock | -30.23M | ||
| Net Income Common Stock (USD) | -30.23M | ||
| Consolidated Income | -30.23M | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -29.48M | ||
| Earning Before Interest & Taxes (USD) | -29.48M | ||
| Weighted Average Shares | 69.72M | ||
| Weighted Average Shares Diluted | 69.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 29.83M | ||
| Cash and Equivalents (USD) | 29.83M | ||
| Investments | 255.42M | ||
| Investments Current | 228.71M | ||
| Investments Non-Current | 26.71M | ||
| Current Assets | 270.00M | ||
| Property, Plant & Equipment Net | 9.44M | ||
| Total Assets | 307.52M | ||
| Debt Current | 2.48M | ||
| Total Debt | 33.35M | ||
| Current Liabilities | 21.49M | ||
| Debt Non-Current | 30.87M | ||
| Total Liabilities | 52.36M | ||
| Accumulated Retained Earnings (Deficit) | -432.01M | ||
| Accumulated Other Comprehensive Income | -1.14M | ||
| Shareholders Equity | 255.17M | ||
| Shareholders Equity (USD) | 255.17M | ||
| Assets Non-Current | 37.52M | ||
| Total Debt (USD) | 33.35M | ||
| Liabilities Non-Current | 30.87M | ||
| Trade and Non-Trade Payables | 1.79M | ||
| Tax Assets | 822.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 423.00K | ||
| Net Cash Flow from Financing | 74.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.79M | ||
| Capital Expenditure | -98.00K | ||
| Issuance (Purchase) of Equity Shares | 3.00K | ||
| Issuance (Repayment) of Debt Securities | 70.00K | ||
| Net Cash Flow from Investing | 23.64M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 23.74M | ||
| Net Cash Flow from Operations | -30.50M | ||
| Share Based Compensation | 4.14M | ||